Ospemifene
2 NDCs across 1 manufacturer|0 Generic,2 Brand
Ospemifene is used to treat atrophy, dyspareunia and menopause, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Feb 26, 2013, and the first generic was approved Feb 13, 2024. In 2024, Medicare Part D spent $8 million on Ospemifene across 17,000 claims for 4,417 beneficiaries.
Ospemifene is available as 2 NDCs from 1 manufacturer (0 generic, 2 brand), with NADAC prices from $8.18 to $8.18 per EA. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
2
0G / 2B
Manufacturers
1
competing in market
Price Spread
$8.18 – $8.18
per EA
7d Activity
avg +0.0% WoW · of 2 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing OSPEMIFENE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
OSPHENA 60 MG TABLET | $8.1777 per EA | 0.00% |
OSPHENA 60 MG TABLET | $8.1777 per EA | 0.00% |
Frequently Asked Questions
What is Ospemifene used to treat?
Ospemifene is used to treat atrophy, dyspareunia and menopause, per the National Library of Medicine's MED-RT classification.
When did Ospemifene become available as a generic?
FDA approved the first generic Ospemifene (ANDA) on Feb 13, 2024.
How much does Medicare spend on Ospemifene?
In 2024, Medicare Part D spent $8 million on Ospemifene across 17,000 claims for 4,417 beneficiaries.
How many Ospemifene products are on the market?
The Ospemifene drug market contains 2 NDCs from 1 manufacturer — 0 generic and 2 brand products.
What is the price range for Ospemifene?
NADAC reference prices for Ospemifene range from $8.1777 to $8.1777 per EA.
Which manufacturers make Ospemifene?
1 manufacturer lists Ospemifene in NADAC. Ranked by number of NDCs, the largest are Duchesnay USA, Inc. (2).
How has the price of Ospemifene changed recently?
Over the past 7 days, 0 Ospemifene NDCs rose and 0 fell, with a market-wide average change of +0.0%.